The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
Open accessAbstract
It is well established that high doses of monomeric immunoglobulin G (IgG) purified from pooled human plasma [intravenous immunoglobulin (IVIG)] confer anti-inflammatory activity in a variety of autoimmune settings. However, exactly how those effects are mediated is not clear because of the heterogeneity of IVIG. Recent studies have demonstrated that the anti-inflammatory activity of IgG is completely dependent on sialylation of the N-linked glycan of the IgG Fc fragment. Here we determine the precise glycan requirements for this anti-inflammatory activity, allowing us to engineer an appropriate IgG1 Fc fragment, and thus generate a fully recombinant, sialylated IgG1 Fc with greatly enhanced potency. This therapeutic molecule precisely defines the biologically active component of IVIG and helps guide development of an IVIG replacement with improved activity and availability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, galactose is required for sialylation with N-acetylneuraminic acid (NeuAc), which in turn can improve the solubility, anti-inflammatory activity, thermal stability and serum half-life of mAbs [8,23–26].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“it is the α2,6-linked NeuAc (main sialic acid linkage in human IgG) that is solely required for the anti-inflammatory activity of IgG mediated by non-canonical IgG-Fc receptors [24].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032
Self-citationAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationThe Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051
Self-citationGlycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 580
Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 413
Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells
Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 399
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 847
Introduction: General Aspects of the Chemical Biology of Glycoproteins
Chaffey, P. K., Guan, X., Wang, L., & Tan, Z. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623823-00001 · Cited by 2
Lo, K.-M., Léger, O. J. P., & Hock, B. M. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch19 · Cited by 2
N‐Glycan Engineering: Constructing the N−GlcNAc Stump
Wu, Q., Dong, S., & Xuan, W. (2022) · ChemBioChem · doi:10.1002/cbic.202200388 · Cited by 2
New and emerging treatments of Guillain–Barré syndrome
Lehmann, H. C., Zhang, G., & Sheikh, K. A. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.925393 · Cited by 2
Phagocytes and Immunoglobulins
Martínez‐Pomares, L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00005-4 · Cited by 2
Biothérapies : vers une deuxième révolution ?
Mouthon, L. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.03.002 · Cited by 2
Chen, G., Zhang, L., Wang, Y., Guo, Y., Liu, H., & Li, Z. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6557 · Cited by 2
Harb, J., Wilson, B. S., & Hermouet, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01761 · Cited by 2
Yoo, E. M., & Morrison, S. L. (2009) · Encyclopedia of Industrial Biotechnology · doi:10.1002/9780470054581.eib044 · Cited by 2
Molina, L. M., Pepi, L. E., Shajahan, A., Doungkamchan, K., Azadi, P., McKim, D. B., & Miller, D. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.26.534240 · Cited by 2
Huang, H., Shivatare, V. S., Tseng, T., & Wong, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.18.572280 · Cited by 2
The anti-inflammatory activity of IgG requires the co-engagement of types I and II Fc receptorsPreprint
Jones, A., Martynyuk, T., Marino, A. E., Bournazos, S., & Ravetch, J. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628704 · Cited by 2
Self-citationYoshida, K., Okuzaki, Y., Nishijima, K.-I., Kyogoku, K., Yamashita, T., Kawabe, Y., Motono, M., Kamihira, M., & Iijima, S. (2013) · Cytotechnology · doi:10.1007/s10616-013-9613-z · Cited by 2
Impact of Glycosylation on Therapeutic Glycoproteins
Mousavi, M., Dehbashi, M., & Movahedi, A. (2016) · British Journal of Applied Science & Technology · doi:10.9734/bjast/2016/29679 · Cited by 1
Sherman, J. D., Karmali, V., Kumar, B., Simon, T. W., Bechnak, S., Panjwani, A., Ciric, C. R., Wang, D., Huerta, C., Johnson, B. E., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae626 · Cited by 1
Microfluidic mimicry of the Golgi-linked N -glycosylation machinery
Isenrich, F. N., Losfeld, M., Aebi, M., & deMello, A. J. (2025) · Lab on a Chip · doi:10.1039/d5lc00005j · Cited by 1
Das, T., Luo, S., Wang, P., Fang, J., Shajahan, A., Pepi, L. E., Dash, S., Maravillas, K., Wickramasekara, R. N., Azadi, P., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2025.141089 · Cited by 1
Zhou, Y., Weiss, S. S., Tan, C., Bittner, P., Harrison, J. A., Tjernberg, L. O., Emmer, Å., & Zenobi, R. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03703 · Cited by 2
Temporal dynamics of IgG-mediated immunometabolic dysfunction: from acute obesity to chronic aging
Kim, S., Kim, J.-H., Lee, H.-L., & Kim, M. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661391 · Cited by 1
Humoral correlates of clinical response to thymectomy in myasthenia gravis
de Sousa, C. D. F., Terroba-Navajas, P., Tzartos, J. S., Orešković, I. D., Pučić‐Baković, M., Lauc, G., Bartsch, Y. C., Kaminski, H. J., & Lünemann, J. D. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103517 · Cited by 1
Intravenous immunoglobulin therapy in viral infections: Lessons learned from COVID-19
Alaka, M., Tuaillon, É., & Desnues, B. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119762 · Cited by 1
A rapid and high-throughput biotechnology quantifies major glycoforms of human IgG1 mAb drugs
Matsumoto, Y., Zhou, L., Ohno, S., Lu, W., Biel, T. G., Fratz‐Berilla, E. J., Ortega‐Rodriguez, U., Houchens, T., Dean, A. Q., Kim, S.-R., et al. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.07.004 · Cited by 1
IgG N-glycosylation in autoimmune diseases
Pumpe, C., & Vermeren, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1933960 · Cited by 1
Crystal Structures of Human IgG-Fc Fragments and Their Complexes with Fcγ Receptors
Sondermann, P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7107-3_3 · Cited by 1
Will sialylation change intravenous immunoglobulin therapy in the future?
Käsermann, F., & Campbell, I. K. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12528 · Cited by 1
Antibody-Mediated Rejection in Kidney Transplantation
Ugarte, R. M., Kiangkitiwan, B., & Haririan, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0342-9_26 · Cited by 1
Fcγ Receptors as Therapeutic Targets
Anthony, R. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00016-9 · Cited by 2
Self-citationShort review – Management of Immune Thrombocytopenia in adults
Weiss, L., & Greil, R. (2010) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-010-0189-4 · Cited by 1
In situ Monitoring of In vitro Sialylation by Inclusion Bodies
Talafová, K. (2011) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000105 · Cited by 1
Update on the Treatment of Acute and Chronic Antibody-mediated Rejection
Park, K.-T., Jung, C. W., & Kim, M.-G. (2013) · Korean Journal of Transplantation · doi:10.4285/jkstn.2013.27.1.6 · Cited by 1
Immunomodulatory Effects of Intravenous Immunoglobulin - Assembling a Jigsaw Puzzle
Mitrevski, M., Marrapodi, R., Camponeschi, A., Todi, L., Granata, G., Leone, M. C., & Fiorilli, M. (2014) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 1
Igg-Reactivity of Intravenous Immunoglobulin Preparations
Öztürk, Ö. G. (2013) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000133 · Cited by 1
Hochdosierte intravenöse Immunglobuline bei dermatologischen Autoimmunerkrankungen
Hoffmann, J. H. O., & Enk, A. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13389_g · Cited by 1
Intravenous Immune Serum Globulin (IVIG) Therapy in Patients with Antibody Immune Deficiency
Ballow, M. C., & Lehman, H. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00017-1 · Cited by 1
Gstöttner, C., Kaur, H., & Wuhrer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822318-5.00002-8 · Cited by 1
Antibody Fc engineering for optimal antibody performance
(2012) · Elsevier eBooks · doi:10.1533/9781908818096.225 · Cited by 1
Multiple antibody and multi-specificity approaches
(2012) · Elsevier eBooks · doi:10.1533/9781908818096.299 · Cited by 1
Effective Assignment of α2,3/α2,6‐Sialic Acid Isomers by LC‐MS/MS‐Based Glycoproteomics
Pett, C., Nasir, W., Sihlbom, C., Olsson, B., Caixeta, V., Schorlemer, M., Zahedi, R. P., Larson, G., Nilsson, J., & Westerlind, U. (2018) · Angewandte Chemie · doi:10.1002/ange.201803540 · Cited by 1
Crystal Structure of Methyl 3-O-α-d-Glucopyranosyl 2-Acetamido-2-Deoxy-α-d-Galactopyranoside Hydrate
Lars Eriksson, A., & Widmalm, G. (2023) · Journal of Chemical Crystallography · doi:10.1007/s10870-023-00979-z · Cited by 1
Sialic acids in autoimmune disorders
Ghosh, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816126-5.00006-8 · Cited by 1
Antiviral Therapies: A Critical Reappraisal
Elsanhoury, A., Linthout, S. V., & Tschöpe, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_17 · Cited by 1
Jain, A., Bruno, K. A., Matsumori, A., Cooper, L. T., Yamani, M., & Fairweather, D. (2022) · Comprehensive Pharmacology · doi:10.1016/b978-0-12-820472-6.00091-8 · Cited by 1
Monoclonal Antibody-Directed Therapy
Kayser, V., & Datta‐Mannan, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2872-4 · Cited by 1
Desensitization Protocols for Organ Transplantation
Lefaucheur, C., & Glotz, D. (2014) · doi:10.1002/9781118873434.ch68 · Cited by 1
Barton, C. R. (2014) · doi:10.18297/etd/80 · Cited by 1
Impacts of glycans attached to therapeutic glycoproteins
Kim, S., Kwon, O., & Oh, D. (2010) · Journal of Plant Biotechnology · doi:10.5010/jpb.2010.37.3.292 · Cited by 1
(2012) · Elsevier eBooks · doi:10.1016/b978-1-907568-37-4.50029-4 · Cited by 1
(2008) · Nature Immunology · doi:10.1038/ni0608-591 · Cited by 1
Gupta, A., Kao, K. S., Yamin, R., Oren, D. A., Goldgur, Y., Du, J. J., Lollar, P., Sundberg, E. J., & Ravetch, J. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.23.525277 · Cited by 1
Self-citationHu, Q., & Wu, H. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-lgj8h · Cited by 1
Sotomayor, B., Donahue, T. C., Mahajan, S. P., Taw, M. N., Hulbert, S. W., Bidstrup, E. J., Owitipana, D. N., Pang, A., Xu, Y., Ghosal, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607630 · Cited by 1
Tsukamoto, Y., Aoki, K., Saiki, W., Tsukamoto, N., Kato, K., Hosokawa, Y., Sato, R., Fujita, Y., Fukazawa, K., Kurebayashi, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.20.639268 · Cited by 1
Experimental Models of Mixed Cryoglobulinemia
Alpers, C. E., Wietecha, T., & Hudkins, K. L. (2011) · Springer eBooks · doi:10.1007/978-88-470-1705-4_18
The Diverse Roles of FcRn: Implications for Antibody Engineering
Ward, E. S., & Ober, R. J. (2012) · Wiley eBooks · doi:10.1002/9783527644827.ch11 · Cited by 1
Cacciuttolo, M. A., Lee, G., Chon, J. H., & Lewis, J. (2009) · Encyclopedia of Industrial Biotechnology · doi:10.1002/9780470054581.eib336
INNATE MECHANISMS REGULATING PERIPHERAL B CELL TOLERANCE
Wermeling, F. (2010) · Figshare
Immunoglobulin Treatment in Polymyositis and Dermatomyositis
Giovanna, M., Pettinari, L., Moretti, R., Logullo, F. O., & Gabrielli, A. (2011) · InTech eBooks · doi:10.5772/22904
Jordan, S. C., Toyoda, M., Kahwaji, J. M., Peng, A., & Vo, A. A. (2010) · doi:10.1002/9781444355628.ch29
Multifactorial aspects of antibody-mediated blood cell destruction
Kapur, R. (2014) · UvA-DARE (University of Amsterdam)
Intravenous immunoglobulin (IVIG): Straight from bench to bedside
von Elstermann, M. (2008) · Functional Glycomics · doi:10.1038/fg.2008.25
Downey, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903830106
Intravenous Immunoglobulins after Liver Transplantation: new insights in mechanisms of action
Tha‐In, T. (2009) · RePub (Erasmus University Rotterdam)
Intravenous immunoglobulin G (IVIg): Properties of dimeric and sialylated IgG
Guhr, T. (2013) · UvA-DARE (University of Amsterdam)
Qualitative and Quantitative Characterization of Therapeutic Antibodies by Native Mass Spectrometry
Rosati, S. (2014) · Utrecht University Repository (Utrecht University)
Novel Fc receptors mediating the anti-inflammatory properties of IgG
Ravetch, J. V. (2010)
Self-citationNew approaches to enzyme replacement therapy for Pompe disease
Cousens, L. P., Mingozzi, F., van der Marel, S., Su, Y. A., Garman, R. D., Ferreira, V., Martin, W. D., Scott, D. W., & Groot, A. S. D. (2012)
Mechanisms of interferon-α inhibition by intravenous immunoglobulin
WIEDEMAN, A. E. (2013) · ResearchWorks at the University of Washington (University of Washington)
Reading and engineering N-linked protein glycosilation in Escherichia coli
Schwarz, F. (2010) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006242775
Lehman, H. K., & Ballow, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00015-x
Zhou, H. (2009) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Factors contributing to the pathogenesis of IgG‐mediated alloimmune disease
Sonneveld, M. E., van der Schoot, C. E., & Vidarsson, G. (2016) · ISBT Science Series · doi:10.1111/voxs.12196
Immunoglobulines polyvalentes par voie intraveineuse
Sacré, K., & Papo, T. (2009) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(09)49788-6
Vestrheim, A. (2013) · NORA - Norwegian Open Research Archives
Bruder, E. D., Richards, J. O., Michel, K., & Oaks, M. K. (2016) · Open Journal of Immunology · doi:10.4236/oji.2016.62005
Cardiomyopathies : Classification, and Treatment
Maisch, B., Noutsias, M., Ruppert, V., Richter, A., & Pankuweit, S. (2012)
Khoo, K. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00715-2
Emerging Principles for the Therapeutic Exploitation of
Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2016)
Mechanism of Action of Immunoglobulin: Sialylated IgG
Takai, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-56039-5_25
Mott, P. J. (2012) · TSpace (University of Toronto)
Immunoglobulin G: A Potential Immuno-modulatory Therapy for Traumatic Spinal Cord Injury
Nguyen, D. H. (2012) · TSpace (University of Toronto)
Identification and Characterization of the Receptor for the Soluble Fibrinogen Like Protein 2 (FGL2)
Liu, H. (2010) · TSpace (University of Toronto)
Marjoram, D. (2016) · TSpace (University of Toronto)
Blondeel, E. J. M. (2018) · UWSpace (University of Waterloo)
Sialylation of anti-histone antibodies in blood serum of systemic lupus erythematosus patients
Mahorivska, I., Bilyy, R. O., Munoz, L. E., i, M. H., Stoika, R. S., & Kit, Y. Y. (2012) · Studia Biologica · doi:10.30970/sbi.0603.239
Methods for chemical mapping of O-GlcNAc in the Drosophila genome
Myschyshyn, M. (2017) · Summit (Simon Fraser University)
関節リウマチ患者におけるインフリキシマブまたはエタネルセプト治療と抗ガラクトース欠損IgG抗体(CARF)値および抗シトルリン化蛋白抗体値:CARF値と疾患活動性は相関する
Motohashi, Y., Kikkawa, K., & Miya, M. (2019) · 臨床リウマチ · doi:10.14961/cra.31.112
Combe, M. (2020) · DalSpace (Dalhousie University)
Antibodies: Friends, Foes, or Both? Lessons From COVID-19 for the Rheumatologist
Rodriguez, M. A., Fuentes-Silva, Y., & Vásquez, G. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001733
Lewis, B. J. B. (2020) · TSpace (University of Toronto)
Gamain, B., Brousse, C., Rainey, N. E., Diallo, B., Paquereau, C.-E., Desrames, A., Ceputyte, J., Semblat, J., Bertrand, O., Gangnard, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-668626/v1
Dionne, B. (2015) · Mspace (University of Manitoba)
Pei, D. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1148890.618063
Grigorian, A., Newton, B. L., & Demetriou, M. (2011) · Wiley eBooks · doi:10.1002/9781118017586.ch8
Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurance
Gómez, I. A., & del Val, I. J. (2021) · Cell engineering · doi:10.1007/978-3-030-79871-0_6
Šenolt, L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726936953.793564297
(2008) · Nature Biotechnology · doi:10.1038/nbt0608-657
Metadata
- Authors
- Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 373-376
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2409116
- OpenAlex
- W2051666192
- Cited by
- 849
- References
- 34
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 29 · 2023: 37 · 2022: 39 · 2021: 39 · 2020: 50 · 2019: 39 · 2018: 45 · 2017: 46 · 2016: 66 · 2015: 58 · 2014: 58 · 2013: 58 · 2012: 68
- FWCI
- 42.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01gm060938-10)
- National Institute of General Medical Sciences (R01GM054045, R01-GM060938, GM60938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- intravenous immunoglobulin, anti-inflammatory activity, IgG Fc fragment, sialylation, N-glycans, glycan engineering, autoimmune disease
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Experimental, Autoimmune Diseases, Carbohydrate Conformation, Galactose, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Mice, Inbred C57BL, Polysaccharides, Receptors, Fc, Recombinant Proteins, Purpura, Thrombocytopenic, Idiopathic, Mice, Inbred NOD, Immunoglobulins, Intravenous, N-Acetylneuraminic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review